SRI International develops advanced technologies including quantum-enabled sensors, photonic chips, and quantum hardware through its leadership in the Quantum Economic Development Consortium, as well as dexterous telemanipulation and service robots, AI-mediated robotic surgery systems, lidar and spectroscopy sensors, and biomedical platforms for drug co-development. It conducts intelligence, surveillance, and reconnaissance systems, human-machine interaction solutions, and sensing technologies under contract. Customers include government agencies, pharmaceutical and biotech companies, and sectors such as mining, space, and healthcare. Key distinguishing technologies involve AI and machine learning, quantum systems, advanced robotics, and precision sensing. The organization is led by CEO David Parekh, along with division presidents Kathlynn Brown for Biosciences and John Crowe for Advanced Technology and Systems. Headquartered in Menlo Park, California, it operates offices across the United States and in Tokyo.